Scalable drug discovery demands phenotypic data that is both mechanistically rich and compatible with high-throughput, AI/ML-driven analysis, yet conventional RNA-seq…

What if AI could design a brand-new protein, from scratch, to tackle heart disease? That’s no longer science fiction. In…

Integrating mechanistic enzymology with precision experimentation techniques and streamlined data simulation capabilities brings new levels of detailed understanding to the…

Here’s why: 1️⃣ Shape-shifting Superstars: Macrocycles boast unique chemical properties that set them apart from conventional small molecules. Their grand…

A lot of people asked me recently why kinetics in drug discovery matter (mostly scientists, but some smart investors too!),…

The integration of machine learning (ML) into small-molecule drug discovery has long been heralded as the game-changer that would bring…

Foundation Models and the Power of Proprietary Experimental Data In recent years, foundation models have revolutionised fields from natural language…

Oxford-headquartered Arctoris progresses programmes from target to hit, lead, and candidate with superior efficiency, accuracy, and confidence. Key to the company’s capabilities is the unique…

Molecular glues are small molecules that can bind to two or more proteins, facilitating their interaction and potentially leading to…